Lee John Sang 4
4 · PhaseBio Pharmaceuticals Inc · Filed Feb 14, 2020
Insider Transaction Report
Form 4
Lee John Sang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
[F1]2020-02-12+100,000→ 100,000 totalExercise: $5.19Exp: 2030-02-12→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date.
Signature
/s/ John Sharp, Attorney-in-fact|2020-02-14